Skip to main content

Table 4 Population prevalence of chronic disease (≥18 years) and proportion aware of condition

From: High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda

Tanzania – Total respondents Mwanza municipality (number = 175) District towns (number = 344) Rural (number = 576)
  Weighted % (95 % CI)a Unweighted Nb Weighted % (95 % CI)a Unweighted Nb Weighted % (95 % CI)a Unweighted Nb
HIV positivec 9.1 % (5.3–15.3) 15 10.3 % (6.5–15.8) 35 6.4 % (3.7–10.9) 37
 Previously diagnosedd 6.0 % (0.9–30.0) 1 34.5 % (16.9–57.7) 12 32.4 % (20.4–47.2) 12
 On treatmente 6.0 % (0.9 -30.0) 1 25.8 % (11.6-48.0) 9 28.7 % (17.1-44.0) 11
Hypertensionf 16.4 % (11.7–22.4) 29 16.8 % (12.6–21.9) 56 17.6 % (13.9–21.9) 107
 Previously diagnosed, on treatment and controlledd,g,h 3.7 % (0.6–18.5) 1 1.7 % (0.2–10.9) 1 0 0
 Previously diagnosed, on treatment and not controlledd,g,h 7.6 % (2.0–24.6) 2 5.4 % (1.5–17.6) 3 2.5 % (0.7–8.7 ) 2
 Previously diagnosed and not on treatmentd,h 23.6 % (14.5–35.9) 7 10.4 % (4.7–21.6) 6 4.4 % (1.8–10.6) 4
 No previous diagnosish 65.2 % (50.4–77.6) 19 82.5 % (69.0–90.9) 46 93.1 % (82.9–97.4) 101
Stage Ii 6.0 % (3.5–10.1) 11 10.7 % (7.4–15.3) 35 12.1 % (9.6–15.1) 74
Stage IIi 8.8 % (5.1–14.8) 15 5.0 % (2.8–8.9 ) 17 5.1 % (3.2–7.9 ) 31
Diabetesj,k 1.9 % (0.7–5.0 ) 3 1.5 % (0.6–3.6 ) 5 0.6 % (0.1–2.8 ) 3
 Previously diagnosedd 70.1 % (14.5–97.0) 2 82.4 % (40.3–97.0) 4 37.7 % (16.3–65.2) 1
 On treatmente 70.1 % (14.5–97.0) 2 41.2 % (7.8 -85.3) 2 37.7 % (16.3-65.2) 1
Heart failurel 3.3 % (1.7–6.4 ) 6 1.4 % (0.8–2.5 ) 5 4.5 % (3.2–6.2 ) 22
 Previously diagnosedd 21.2 % (2.3–75.8) 1 0 0 0 0
COPD/asthmam,n 3.5 % (1.5–7.9 ) 6 2.7 % (1.3–5.7 ) 9 3.9 % (2.2–6.9 ) 25
 Previously diagnosedd 0 0 11.8 % (1.3 -58.0) 1 8.5 % (2.2 -27.3) 2
 On treatmente 0 1 11.8 % (1.3 -58.0) 1 3.6 % (0.6 -19.8) 1
Epilepsyo 0.6 % (0.1–3.8 ) 1 0.8 % (0.3–2.2 ) 3 1.6 % (0.7–3.4 ) 8
Any CD (NCDs and HIV infection) 29.5 % (20.2-40.9) 52 28.0 % (21.7-35.2) 95 29.1 % (25.1-33.4) 172
 More than one CD 4.7 % (2.3 -9.4 ) 8 4.7 % (2.5 -8.5 ) 17 4.1 % (2.3 -7.2 ) 25
Any NCD 22.6 % (15.3-32.1) 40 20.8 % (15.3-27.7) 70 25.0 % (21.3-29.1) 148
 More than one NCD 2.9 % (1.3 -6.2 ) 5 2.0 % (1.0 -4.0 ) 7 2.8 % (1.4 -5.4 ) 16
Uganda - Total respondents Entebbe municipality (number = 206) District towns (number = 278) Rural (number = 432)
HIV positivec 12.2 % (9.4–15.7) 25 5.5 % (2.4–12.4) 24 11.6 % (8.0–16.6) 49
 Previously diagnosedd 40.0 % (22.5–60.5) 10 26.4 % (8.0–59.5) 8 51.9 % (34.8–68.5) 25
 On treatmente 36.0 % (19.5-56.6) 9 26.4 % (8.0 -59.5) 8 49.3 % (33.2-65.6) 24
Hypertensionf 22.3 % (16.2–30.0) 46 19.2 % (14.0–25.6) 49 26.3 % (23.0–29.9) 111
 Previously diagnosed, on treatment and controlledd,g,h 2.2 % (0.3–15.4) 1 3.4 % (0.5–20.8) 2 3.4 % (0.9–12.2) 3
 Previously diagnosed, on treatment and not controlledd,g,h 13.0 % (4.0–34.9) 6 12.8 % (4.3–32.3) 4 5.1 % (2.4–10.5) 5
 Previously diagnosed and not on treatmentd,h 15.2 % (7.4–28.9) 7 6.4 % (1.6–22.2) 2 11.9 % (7.1–19.2) 12
 No previous diagnosish 69.6 % (52.0–82.8) 32 77.3 % (59.2–88.9) 41 79.7 % (74.6–84.0) 91
Stage Ii 12.1 % (7.3–19.3) 24 11.1 % (7.7–15.9) 26 16.9 % (14.3–19.9) 68
Stage IIi 7.5 % (4.6–12.0) 15 5.4 % (2.8–10.4) 17 7.8 % (5.4–11.0) 35
Diabetesj,p 2.4 % (0.9–6.2 ) 5 3.8 % (1.8–7.8 ) 7 3.0 % (1.4–6.2 ) 10
 Previously diagnosedd 80.0 % (34.6–96.8) 4 67.0 % (15.4–95.8) 5 40.0 % (22.3–60.8) 4
 On treatmente 80.0 % (34.6-96.8) 4 50.5 % (11.9-88.5) 4 30.0 % (15.2-50.6) 3
Heart failurel 9.2 % (5.5–15.1) 19 2.6 % (1.1–5.9 ) 7 3.0 % (1.5–6.0 ) 12
 Previously diagnosedd 5.3 % (0.7–30.9) 1 23.9 % (2.7–78.3) 1 0 0
COPD/asthmam,q 3.5 % (1.9–6.3 ) 7 2.2 % (0.9–5.1 ) 11 9.6 % (6.2–14.4 ) 41
 Previously diagnosedd 0 0 0 0 3.3 % (0.5–18.3 ) 1
 On treatmente 0 0 0 0 3.3 % (0.5–18.3 ) 1
Epilepsyo,r 0 0 0 0 1.1 % (0.3–3.3 ) 5
Any CD (NCDs and HIV infection) 39.3 % (35.4-43.4) 81 28.6 % (22.3-35.8) 84 44.7 % (38.9-50.6) 189
 More than one CD 7.3 % (5.5 -9.6 ) 15 4.5 % (2.3 -8.4 ) 12 8.9 % (6.3 -12.4) 38
Any NCD 31.1 % (26.7-35.8) 64 23.8 % (17.9-30.9) 64 36.7 % (32.8-40.8) 156
 More than one NCD 5.3 % (3.5 -8.0 ) 11 3.8 % (1.8 -7.8 ) 9 5.6 % (3.6 -8.6 ) 23
  1. aWeighted estimates, adjusted for survey design with sampling weights applied. See footnote 1 of Table 1; bactual number of respondents, without sampling weights applied; 3HIV diagnosis missing for 8 participants from Mwanza municipality, 1 from Entebbe municipality, and for 1 rural participant in Uganda (majority refused blood test); dparticipants reported having been told by a doctor in the past 12 months that they have the condition; denominator is those diagnosed with the condition during the survey; eparticipants reported currently receiving medication for the condition; denominator is those diagnosed with the condition during the survey; fsystolic BP ≥140 and/or diastolic BP ≥90, in 3rd measurement at a single visit, or currently receiving drugs for high blood pressure. Missing for 1 participant from Mwanza municipality and 1 rural participant in Tanzania; gparticipants reported currently receiving drugs for high blood pressure; ‘controlled’ defined as systolic BP <140 and diastolic BP <90); hdenominator is N with hypertension; istage I: systolic BP ≥140 and <160 and/or diastolic BP ≥90 and <100. Stage II: systolic BP ≥160 and/or diastolic BP ≥100. Excludes participants currently receiving drugs for high blood pressure: 21 in Uganda and 9 Tanzania; jrandom blood glucose (RBG) >11.1, or RBG 7 to 11.1 and fasting blood glucose (FBG) ≥7 mmol/L, or currently receiving insulin or oral diabetes drugs in the last two weeks; kmissing for 3 participants from Mwanza municipality, 7 from district towns and for 12 rural participants (majority refused RBG or did not return for FBG test); lorthopnea or paroxysmal nocturnal dyspnea (PND) and at least 2/3 of edema, breathlessness on excersion (BOE) and heart rate (HR) >120, or orthopnea and PND and at least 1/3 of edema, BOE and HR >120; mFEV1/FVC <0.70; nCOPD/asthma diagnosis missing for 4 participants from Mwanza municipality, 8 from district towns and for 17 rural participants (mostly because test was contraindicated or participant unable to perform test); oreports having had a seizure in past 12 months, or currently taking medication for epilepsy; pmissing for 1 participant from district towns and for 2 rural participants; qCOPD/asthma diagnosis missing for 4 participant from Entebbe municipality, 9 from district towns and for 30 rural participants (majority were unable to perform the spirometry test); rmissing for one participant from Entebbe municipality. BP, blood pressure; CD, chronic disease; CI, confidence interval; COPD, chronic obstructive pulmonary disease; NCD, non-communicable disease